Anti-natalizumab antibodies during 8 years of natalizumab treatment: effect on natalizumab concentration and α4-integrin receptor saturation

J Neurol. 2019 Jul;266(7):1804-1805. doi: 10.1007/s00415-019-09327-8. Epub 2019 Apr 19.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies / analysis*
  • Female
  • Humans
  • Immunologic Factors / immunology*
  • Immunologic Factors / therapeutic use
  • Integrin alpha4 / immunology
  • Integrin alpha4 / metabolism*
  • Multiple Sclerosis, Relapsing-Remitting / complications
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy
  • Natalizumab / immunology*
  • Natalizumab / therapeutic use

Substances

  • Antibodies
  • Immunologic Factors
  • Natalizumab
  • Integrin alpha4